COVID‐19: A Catalyst to Accelerate Global Regulatory Transformation
- Resource Type
- Source
- Clinical Pharmacology & Therapeutics. 109:1390-1392
- Subject
Pharmacology Digital Technology 2019-20 coronavirus outbreak Clinical Audit Coronavirus disease 2019 (COVID-19) SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Decision Making COVID-19 Computational biology Global Health Risk Assessment Telemedicine COVID-19 Drug Treatment Transformation (genetics) Interinstitutional Relations Drug Development Political science Humans Pharmacology (medical) Cooperative Behavior Drug Approval - Language
- ISSN
- 1532-6535
0009-9236